Short interest in Aligos Therapeutics Inc (NASDAQ:ALGS) decreased during the last reporting period, falling from 291.51K to 283.76K. This put 12.63% of the company's publicly available shares short.

Short interest for Aligos Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Aligos Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 549.48K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.